Dual Antiplatelet Therapy Duration After Multivessel Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention

CONCLUSIONS: The adoption of short DAPT duration was still low in this trial conducted after the release of the STOPDAPT-2 trial results. The 1-year incidence of cardiovascular events was not different between the shorter and longer DAPT groups, suggesting no apparent benefit of prolonged DAPT in reducing cardiovascular events even in patients who undergo multivessel PCI.PMID:37197941 | DOI:10.1253/circj.CJ-23-0141

Source: Circulation Journal - May 17, 2023 Category: Cardiology Authors: Ko Yamamoto Hiroki Shiomi Takeshi Morimoto Akiyoshi Miyazawa Hiroki Watanabe Sunao Nakamura Satoru Suwa Takenori Domei Koh Ono Hiroki Sakamoto Masataka Shigetoshi Ryoji Taniguchi Hideki Okayama Takafumi Yokomatsu Masahiro Muto Ren Kawaguchi Koichi Kishi M Source Type: research